Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden

被引:19
作者
Huang, YM
Liu, X
Steffensen, K
Sanna, A
Arru, G
Fois, ML
Rosati, G
Sotgiu, S
Link, H
机构
[1] Karolinska Inst, Div Neuroimmunol, Neurotec Dept, S-14186 Huddinge, Sweden
[2] Karolinska Inst, Novum, Dept Biosci, Huddinge, Sweden
[3] Univ Sassari, Inst Clin Neurol, I-07100 Sassari, Italy
来源
MULTIPLE SCLEROSIS | 2005年 / 11卷 / 01期
关键词
IDO; IL-6; IL-12; multiple sclerosis; RT-PCR; TNF-alpha;
D O I
10.1191/1352458505ms1127oa
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Subjects from Sardinia, Italy, are relatively homogeneous compared to Swedes. Although ethnically distant, both populations have similarly high multiple sclerosis ( MS) incidence rates. Pro- and anti- inflammatory cytokines and their receptors, signalling molecules and other immune response- associated factors might influence MS pathogenesis, though definite proof is missing. The study of populations with similar MS incidence but different genetic and environmental background could make possible the definition of factors that relate to such background differences. We selected untreated female MS patients from Sassari, Sardinia, and Stockholm, Sweden, and corresponding sex- and age- matched healthy controls ( HC), to study blood mononuclear cells ( MNC) for mRNA expression of 20 immune response- related genes considered relevant in MS, employing real- time PCR. Higher expression of IL- 12p40 mRNA was confined to MS from both Sassari and Stockholm, compared to corresponding HC. MS patients from Sassari, but not Stockholm, expressed higher TNF-alpha compared to corresponding HC. MS patients from Stockholm, but not Sassari, expressed higher IL- 6. Indoleamine 2,3 dioxygenase ( IDO), a molecule necessary in tolerance induction, was lower in MS from Stockholm compared to corresponding HC. This was not observed in Sassari. No differences were detected for other members of the IL- 12 family, other Th1 and Th2 cytokines, and the signalling molecules Stat 4 and 6. The results corroborate a pro- inflammatory state in MS as reflected by high expression of IL- 12, TNF- alpha and IL- 6, although the extent of expression of TNF- alpha, IL- 6 and IDO differs between strictly matched MS patients from different high- incidence areas. This might result from genetic and/ or environmental differences. They may account for some of the discrepancies regarding immune response- related molecules previously reported in MS. In conclusion, a pro- inflammatory state exists in MS patients from Sassari as well as Stockholm. The changes of pro- inflammatory and other immune response- related variables differ however between the two MS populations. This may be attributed to the genetic and/ or environmental background.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 35 条
[1]
Defective regulation of IFNγ and IL-12 by endogenous IL-10 in progressive MS [J].
Balashov, KE ;
Comabella, M ;
Ohashi, T ;
Khoury, SJ ;
Weiner, HL .
NEUROLOGY, 2000, 55 (02) :192-198
[2]
STAT proteins:: From normal control of cellular events to tumorigenesis [J].
Calò, V ;
Migliavacca, M ;
Bazan, V ;
Macaluso, M ;
Buscemi, M ;
Gebbia, N ;
Russo, A .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 197 (02) :157-168
[3]
Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation [J].
Cannella, B ;
Raine, CS .
ANNALS OF NEUROLOGY, 2004, 55 (01) :46-57
[4]
CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3
[5]
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[6]
Genetics of multiple sclerosis [J].
Dyment, DA ;
Ebers, GC ;
Sadovnick, AD .
LANCET NEUROLOGY, 2004, 3 (02) :104-110
[7]
Increased release of interleukin-12p40 in MS - Association with intracerebral inflammation [J].
Fassbender, K ;
Ragoschke, A ;
Rossol, S ;
Schwartz, A ;
Mielke, O ;
Paulig, A ;
Hennerici, M .
NEUROLOGY, 1998, 51 (03) :753-758
[8]
FREI K, 1991, J NEUROIMMUNOL, V31, P147
[9]
Tolerance, DCs and tryptophan: much ado about IDO [J].
Grohmann, U ;
Fallarino, F ;
Puccetti, P .
TRENDS IN IMMUNOLOGY, 2003, 24 (05) :242-248
[10]
Hoffman F. M., 1989, J EXP MED, V170, P607